George Kemble
Vermogen: 616 637 $ op 31-10-2026
Vermogen: 616 637 $ op 31-10-2026
George W.
Kemble is Executive Chairman at Sagimet Biosciences, Inc. since 2022.
Formerly, Dr. Kemble was Senior Vice President-Research & Development at MedImmune LLC from 2001 to 2011.
Other former roles include Director at LigoCyte Pharmaceuticals, Inc. and Staff Scientist at MedImmune Vaccines, Inc. Education includes a doctorate from Stanford University and an undergraduate degree from Santa Clara University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-08-2026 | 62.161 ( 0,09% ) | 616 637 $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Voorzitter | 24-10-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Corporate Officer/Principal | - |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau